Case Reports
Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia
Affiliations
- PMID: 18460249
Item in Clipboard
Case Reports
Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia
J Coll Physicians Surg Pak.
2008 Mar.
Abstract
Imatinib mesylate is a BCR-ABL tyrosine kinase inhibitor used in the management of chronic myeloid leukemia. It is a safe and well-tolerated agent with a few manageable side effects. We are reporting a case of imatinib-related fatal bone marrow aplasia after complete cytogenetic response.
Similar articles
-
Hematological and molecular response evaluation of CML patients on imatinib.J Assoc Physicians India. 2007 Feb;55:109-13. J Assoc Physicians India. 2007. PMID: 17571739
-
Massive bone marrow necrosis in a patient with chronic myelocytic leukemia following imatinib mesylate therapy.Haematologica. 2004 Sep;89(9):ECR32. Haematologica. 2004. PMID: 15377484 No abstract available.
-
Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment.J Clin Oncol. 2006 Jan 20;24(3):454-9. doi: 10.1200/JCO.2005.03.2011. J Clin Oncol. 2006. PMID: 16421422
-
Practical management of patients with chronic myeloid leukemia receiving imatinib.J Clin Oncol. 2003 Apr 15;21(8):1637-47. doi: 10.1200/JCO.2003.11.143. Epub 2003 Mar 13. J Clin Oncol. 2003. PMID: 12668652 Review.
-
[The role of imatinib in the treatment of acute lymphoid leukemias].Orv Hetil. 2005 May 1;146(18 Suppl 1):905-10. Orv Hetil. 2005. PMID: 15921303 Review. Hungarian.
Cited by
-
MDR1/ABCB1 gene polymorphisms in patients with chronic myeloid leukemia.Blood Res. 2015 Sep;50(3):154-9. doi: 10.5045/br.2015.50.3.154. Epub 2015 Sep 22. Blood Res. 2015. PMID: 26457282 Free PMC article.
-
Synchronous presentation of chronic myeloid leukemia with carcinoma penis: a rare presentation.J Clin Diagn Res. 2014 Sep;8(9):QD01-2. doi: 10.7860/JCDR/2014/8760.4827. Epub 2014 Sep 20. J Clin Diagn Res. 2014. PMID: 25386499 Free PMC article.
-
Evaluation of Cytopenias Occurring in Imatinib Treated Chronic Myeloid Leukemia (CML) Patients.Indian J Hematol Blood Transfus. 2010 Jun;26(2):56-61. doi: 10.1007/s12288-010-0030-6. Epub 2010 Oct 5. Indian J Hematol Blood Transfus. 2010. PMID: 21629637 Free PMC article.
-
Aplasia in Chronic Phase CML Post-TKI Therapy: A Management Dilemma.Case Rep Hematol. 2019 Sep 22;2019:4861673. doi: 10.1155/2019/4861673. eCollection 2019. Case Rep Hematol. 2019. PMID: 31662918 Free PMC article.
-
Ethnic Differences in Hematologic Toxicity from Imatinib in Patients with Gastrointestinal Stromal Cell Tumor (GIST): Coincidence or a Real Phenomenon.Eurasian J Med Oncol. 2019;3(3):182-185. doi: 10.14744/ejmo.2019.94710. Eurasian J Med Oncol. 2019. PMID: 32104790 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous